NITEC PHARMA AG has a total of 41 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, Argentina and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GALMED RES AND DEVELOPMENT LTD, JOUVEINAL LAB and PHOTONAMIC GMBH & CO KG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Argentina | 3 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Brazil | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | Norway | 2 | |
#11 | Singapore | 2 | |
#12 | Taiwan | 2 | |
#13 | China | 1 | |
#14 | EAPO (Eurasian Patent Organization) | 1 | |
#15 | Hong Kong | 1 | |
#16 | Israel | 1 | |
#17 | Japan | 1 | |
#18 | Morocco | 1 | |
#19 | Malaysia | 1 | |
#20 | New Zealand | 1 | |
#21 | Tunisia | 1 | |
#22 | Ukraine | 1 | |
#23 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Schaeffler Achim | 19 |
#2 | Schaffler Achim | 16 |
#3 | Witte Stephan | 7 |
#4 | Achim Schaeffler | 2 |
#5 | Grenier Pascal | 2 |
#6 | Vergnault Guy | 2 |
#7 | Schoffler Achim | 1 |
#8 | Kirwan John R | 1 |
#9 | Achim Schaffler A | 1 |
#10 | Schäffler Achim | 1 |
Publication | Filing date | Title |
---|---|---|
AU2013245436A1 | Delayed-release glucocorticoid treatment of rheumatoid disease | |
AU2010207740A1 | Delayed-release glucocorticoid treatment of asthma | |
NZ582836A | Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage | |
UA96457C2 | Delayed-release glucocorticoid treatment of rheumatoid disease | |
KR20070098989A | Tablets with site time-controlled gastrointestinal release of active ingredient | |
US2006057200A1 | Tablets with site- and time-controlled gastrointestinal release of active ingredient |